howdy all...
can anyone tell me where to find or what its called -- a roster or list comparing
volume and price break down...I've seen it posted a few times but I cant find
it on s-trade...thanks..
==iceman7==
howdy all...
can anyone tell me where to find or what its called -- a roster or list comparing
volume and price break down...I've seen it posted a few times but I cant find
it on s-trade...thanks..
==iceman7==
Reimagining Montessori with Technology Let's take a stroll down the road less traveled—the intersection of Montessori education and tech. For over a century, Montessori schools have valued individual child development, autonomy, and a purpose-driven environment. But let's face it, their technology hasn't always had the same handcrafted finesse. That's where illumine...
Continue ReadingA Step Towards Recognition You know the old saying: innovation never sleeps. Well, Paradigm Therapeutics seems to have taken that to heart. The company's embarked on a peculiar yet promising journey with SD-101 (Zorblesia™), and here they are, basking in the glow of another nomination for the 2026 Prix Galien USA "Best Start-Up" award. It’s their second shot at this...
Continue Reading
Eichman Joins Partner Valuation Advisors as MD Turns out the buzz in real estate appraisal isn’t just about property values these days; it's about who's valuing them. Just ask Partner Valuation Advisors, who are realigning their chess pieces by bringing seasoned pro Justin Eichman, MAI, on board as Managing Director. Talk about playing your cards right. A Heavyweight in...
Continue Reading
Brewing a better ad with AI isn't just about the model you plug in—it's about the wizardry wrapping around it. Omneky's latest caper in the AI advertising game has snagged the spotlight, pulling a hearty 8.8 taste score on a recent TasteBench comparison. That's not a minor tweak, folks, but a whopping 1.2-point lead over the shadow-chasing curves of the next...
Continue Reading
A New Era for Parkinson's Disease Prevention The Parkinson's Foundation has rolled out its battle plan to take on Parkinson's disease from the ground up, shifting gears from managing symptoms to stopping the illness before it starts. It's about damn time, too. With the disease being the fastest-growing neurodegenerative disorder and impacting 10 million people worldwide,...
Continue Reading
Ever noticed how the air vibrates just a bit more when major players like NYSE and Snowflake start shaking hands at big-league events like TechCrunch Disrupt? You'd better believe we're seeing a fresh brew of opportunities and challenges in the market as these titans lock horns and share insights. It's no small feat when the financial nerve center partners into the tech...
Continue Reading
A New Spin on Engineering Careers Sometimes it feels like every corner I turn in this market maze, there’s something about AI. It’s not just chirping in the tech world anymore; it’s banging on the doors of sectors like engineering, aerospace, and manufacturing. And now, VetsinTech is tossing its hat into the AI ring with a fresh program aimed at blending military...
Continue Reading
The Gathering of Mortgage Titans You don't just waltz into the mortgage world with a $2 billion track record and expect folks not to notice. Will Mullinix, a name that's become synonymous in the Carolinas with mortgage mastery, has decided to bring his influential Mullinix Mortgage Group under the banner of New American Funding. Talk about a power play. This bold strategy...
Continue Reading
Treating Crohn's: New Hope on the Horizon Folks, let me tell you, the landscape for treating Crohn's disease just got a bit more interesting. AbbVie's Phase 3 AFFIRM study has brought some attention-grabbing data on the table, showcasing the potential of their drug, SKYRIZI® (risankizumab-rzaa). This ain't just another run-of-the-mill study; these results could be a...
Continue Reading
Transform Your Home's Curb Appeal Without Breaking The Bank Every homeowner knows that feeling when you look at your house one day and think, "This could use a little something." Say you're strolling through a neighborhood in Fulton, N.Y., and notice a gem. It's not a brand new build, but it gleams with character. You bet it's had a few smart touches that could apply...
Continue Reading
Enhancing Investor Rights in Ibotta, Inc. Class Action The Rosen Law Firm, recognized for its commitment to global investor rights, is reaching out to purchasers of Ibotta, Inc. (NYSE: IBTA) regarding the recent developments surrounding its initial public offering (IPO). Investors who participated in the IPO may have the chance to be part of a class action lawsuit that...
Continue Reading
GETESA and Comviva Join Forces to Revolutionize Digital Payments GETESA Money S.A., a prominent subsidiary of GETESA, is set to introduce pioneering digital payment services using Comviva's mobiquity® Pay platform. This strategic partnership marks a significant step towards enhancing digital financial transactions, aiming to foster a cash-lite economy. Innovative Payment...
Continue ReadingUnderstanding the Semiconductor Landscape Investors and analysts alike are continually on the lookout for valuable insights in the ever-changing landscape of the semiconductor industry. A closer examination of key players, such as Monolithic Power Systems (NASDAQ: MPWR), can reveal a lot about market trends and company performance. By comparing financial metrics and...
Continue Reading
SendCutSend Drives Business Growth with Innovative Tools SendCutSend has positioned itself as a key player in American manufacturing by offering robust enterprise features for various industries. The company is experiencing a significant surge in demand for its tailored business tools that cater specifically to the needs of engineering teams, purchasing departments, and...
Continue Reading
SciBase Holding AB (STO: SCIB) has stirred the pot with its latest claims about Nevisense and atopic dermatitis predictions—this study hit the radar on February 17, 2026. It’s set to be presented at the AAAAI conference from February 27 to March 2. Sounds like a breakthrough, right? Well, let’s dissect what this really means for traders sitting on that stock....
Continue Reading